Seouleaguer Co Ltd
KOSDAQ:043710
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its Industry Average (13.9), the stock would be worth ₩-614.09 (168% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -20.5 | ₩905 |
0%
|
| Industry Average | 13.9 | ₩-614.09 |
-168%
|
| Country Average | 8.5 | ₩-377.07 |
-142%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| KR |
S
|
Seouleaguer Co Ltd
KOSDAQ:043710
|
78.3B KRW | -20.5 | -9 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
98.3B USD | 14.2 | 55.8 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 7.8 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.9B USD | 0 | 12.4 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.4B EUR | 9.5 | 18.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.2B EUR | 9.1 | 23.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.6B USD | 12.3 | 22.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.5B USD | 12.3 | 25.6 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.1B EUR | 5.4 | 11.2 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.8B USD | -31 | -28.4 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 7.1 | 13.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 5.3 |
| Median | 8.5 |
| 70th Percentile | 15.6 |
| Max | 24 013.5 |
Other Multiples
Seouleaguer Co Ltd
Glance View
SEOULEAGUER Co., Ltd. engages in the manufacture and sale of accessories and peripherals for mobile devices. The company is headquartered in Seoul, Seoul. The company went IPO on 2002-07-11. The firm operates its business through four segments. The Healthcare Business segment distributes medicines and cosmetics. The Management Service Organization (MSO) Business segment involves in the advertising and real estate lease business. The Medical Business segment provides medical services such as skin care. The Mobile Accessory segment offers mobile accessories and peripherals including cases, cradles, chargers, bluetooth and others.
